Nava Zisapel
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease.
Journal: The journal of prevention of Alzheimer's disease
Published: May 11, 2022
Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder.
Journal: Expert review of clinical pharmacology
Published: March 14, 2022
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: August 21, 2019
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
Journal: Journal of autism and developmental disorders
Published: May 13, 2019
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: August 23, 2018
New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation.
Journal: British journal of pharmacology
Published: July 20, 2017
CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
Journal: Journal of Alzheimer's disease : JAD
Published: May 28, 2017
Paediatric use of melatonin: Letter to the Editor regarding the manuscript "Current role of melatonin in pediatric neurology:Clinical recommendations" by Bruni et al. Eur J Paediatr Neurol. 2015 Mar;19(2):122-33.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: May 29, 2016
Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
Journal: Nature and science of sleep
Published: February 14, 2015
Current Phase II investigational therapies for insomnia.
Journal: Expert opinion on investigational drugs
Published: November 26, 2014
Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
Journal: International clinical psychopharmacology
Published: July 24, 2014
Last Updated: 09/26/2026